Paper Details

  1. Home
  2. Paper Details

A Comparative Study of Intralesional Vitamin D3, Measles Mumps Rubella Vaccine, and Tuberculin Purified Protein Derivative in the Treatment of Recalcitrant Warts: An Approach to Solve a Therapeutic Conundrum.

Author: JainSrishti, MarfatiaYogesh S

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Current treatments for human papilloma virus (HPV) warts are ablative and only act on treated lesions, leading to high recurrence rates. Intralesional immunotherapy may be a more effective treatment as it has the potential to act on both treated and distant lesions.
Paper Details　
Original Abstract of the Article :
Human papilloma virus infects and proliferates in skin or mucosal cells to cause warts. Most of the current therapeutic modalities are ablative, act only on treated lesions, and lack a well-defined treatment endpoint. These being blind procedures, recurrence rates are high, owing to the remnant viru...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675347/

データ提供：米国国立医学図書館（NLM）

Tackling Recalcitrant Warts: Exploring New Immunotherapeutic Approaches

This study investigates the use of intralesional immunotherapy in treating recalcitrant warts, a common skin condition caused by the human papillomavirus (HPV). The researchers explored the effectiveness of intralesional injections of vitamin D3, measles mumps rubella vaccine, and tuberculin purified protein derivative (PPD) in treating recalcitrant warts. This study provides valuable insights into the potential of intralesional immunotherapy for treating recalcitrant warts, exploring various immunotherapeutic approaches.

Intralesional Immunotherapy Shows Promise in Treating Recalcitrant Warts

The study's findings suggest that intralesional immunotherapy may be a promising approach for treating recalcitrant warts, potentially offering a more effective and less invasive treatment option compared to traditional ablative therapies. The researchers' exploration of different immunotherapeutic agents opens up new avenues for treating this persistent condition.

Navigating the Complex World of Wart Treatment

Treating warts can be like navigating a desert landscape, with challenges and uncertainties along the way. This research explores promising new approaches to treating recalcitrant warts, offering hope for patients who have struggled with persistent HPV infections.

Dr. Camel's Conclusion

This study provides a valuable contribution to the search for effective treatments for recalcitrant warts. The researchers' exploration of intralesional immunotherapy with different agents offers a glimmer of hope for patients who have not responded well to traditional therapies. Further research is needed to fully understand the potential of intralesional immunotherapy in treating recalcitrant warts and to identify the most effective agents and treatment protocols.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-04-29
Further Info :

Pubmed ID

34980956

DOI: Digital Object Identifier

PMC8675347

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.